Cargando…
Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
Comparative analyses of the immunogenicity and reactogenicity of homologous and heterologous SARS-CoV-2 vaccine-regimens will inform optimized vaccine strategies. Here we analyze the humoral and cellular immune response following heterologous and homologous vaccination strategies in a convenience co...
Autores principales: | Klemis, Verena, Schmidt, Tina, Schub, David, Mihm, Janine, Marx, Stefanie, Abu-Omar, Amina, Ziegler, Laura, Hielscher, Franziska, Guckelmus, Candida, Urschel, Rebecca, Wagenpfeil, Stefan, Schneitler, Sophie, Becker, Sören L., Gärtner, Barbara C., Sester, Urban, Sester, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366133/ https://www.ncbi.nlm.nih.gov/pubmed/35953492 http://dx.doi.org/10.1038/s41467-022-32321-0 |
Ejemplares similares
-
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
por: Schmidt, Tina, et al.
Publicado: (2021) -
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens
por: Hielscher, Franziska, et al.
Publicado: (2022) -
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
por: Schmidt, Tina, et al.
Publicado: (2021) -
High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
por: Schub, David, et al.
Publicado: (2020) -
Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination
por: Lim, So Yun, et al.
Publicado: (2021)